We would like to thank Frankfurter Sparkasse for recognising our important research work, for the many years of partnership and for the fantastic video with our board member Uwe Menger.
Since our foundation 30 years ago, we have been working intensively with our researchers to improve the chances of recovery for children with cancer.
We would like to join Frankfurter Sparkasse in appealing to you to support our work so that we can one day cure cancer in all children and young people.
The “Frankfurt Foundation for Children with Cancer” was established in 1994 by the association “Hilfe für krebskranke Kinder Frankfurt e. V.”. After more than 25 years in the same guise, the “Frankfurt Foundation for Children with Cancer” now presents itself with a new face of its own.
The change of appearance does not change our goal, which we have been pursuing since the foundation was established: All children suffering from cancer should be given a chance for a cure and a good, long life without late effects.
With this aim in mind our researchers and all other employees at the Dr. Petra Joh-Haus continue to work with great passion and unwavering commitment.
Please remain loyal to us – we still need your support.
We look forward to receiving your feedback on our new website. Thank you.
Marcus Klüssendorf, Uwe Menger, Dr. Florian Rothweiler, Ingo Nehrbaß
The G. and I. Leifheit Foundation Nassau supports the worldwide unique collection of therapy-resistant cancer cells, the “Resistant Cancer Cell Line Collection” (RCCL-Collection), over three years with a grant of 250,000 euros annually. The Managing Director of the G. and I. Leifheit Foundation Nassau, Ingo Nehrbaß, is pleased to be able to make the announcement during the symbolic cheque presentation on 9 July 2021 at the Frankfurt Foundation for Children with Cancer. The funding commitment is made quite in accordance with Günter Leifheits’ personal philosophy: “It must serve people!”
The RCCL Collection is maintained and continuously expanded by the Interdisciplinary Laboratory for Paediatric Tumour and Virus Research (Prof. Jindrich Cinatl) in collaboration with the University of Kent (Prof. Martin Michaelis) (https://research.kent.ac.uk/industrial-biotechnology-centre/the-resistant-cancer-cell-line-rccl-collection/). The research activities of Prof. Cinatl’s working group take place in the Dr. Petra Joh-Haus of the Frankfurt Foundation for Children with Cancer.
With more than 2,500 therapy-resistant cancer cells, the RCCL Collection represents a unique model for (paediatric) cancer research worldwide. The cells from the RCCL Collection help to investigate molecular resistance mechanisms in tumours, identify new active substances and thus overcome resistance. Effects of already approved substances from other medical fields are also tested against tumour cells with the help of resistant cells from the RCCL Collection (drug repurposing). The aim of this research is to find substances that – with as few side effects as possible – are effective against resistant cancer cells where other therapeutic agents fail. In the corona pandemic, cells from the RCCL Collection are also used in research on SARS-CoV-2, thus -as a positive side effect- making an important worldwide scientific research contribution.
“The scientific presentation about the importance of the RCCL Collection for cancer research and its global reach, as well as the interactive exchange with researchers, represented by Dr Florian Rothweiler, completely convinced us,” said Ingo Nehrbaß during his visit to Frankfurt.
The partnership with the G. and I. Leifheit Foundation together with their generous support is of great importance to us. This exemplary support helps us with the further development of our goal to be able to cure 100 percent of children and adolescents suffering from cancer. Since children are our future, the research of the Frankfurt Foundation for Children with Cancer focuses on childhood cancer as a first step. In successful cases the applicability in adults is an immediate consequence.
We would like to express our sincere thanks to the Board of Directors of the G. u. I. Leifheit Foundation for this extremely significant support.
“No matter how bad the times may be, one must not disregard the important things in life”. With this conviction, Volker Bertaloth from Ober-Ramstadt presented a donation of 500 euros to our Managing Director Marcus Klüssendorf on 23 March 2021. It is a matter of the heart for Volker Bertaloth and his family to support the research work of the Frankfurt Foundation for Children with Cancer, even in the current stressful overall situation.
For this wonderful commitment we say a heartfelt THANK YOU!
Marcus Klüssendorf, Dr. Constantin H. Alsheimer, Uwe Menger, Dr. Jürgen Vogt
Over the past ten years, Mainova has supported the research of the Frankfurt Foundation for Children with Cancer with a total of around 250,000 euros. Apart from that, the regional energy supplier will continue its commitment. This was announced today by Mainova CEO Dr. Constantin H. Alsheimer during the symbolic handing-over of the donation at the foundation’s research house.
“My thanks go to all employees and volunteers of the Frankfurt Foundation for Children with Cancer for their high level of personal commitment. Their commitment to the children and families affected is encouraging and deserves our support. We provide this support in the form of an annual donation of 25,000 euros. As a regional company and reliable partner, we are helping our fellow men in need and assume social responsibility,” emphasised Dr. Alsheimer. During the appointment he also presented 200 Mainova comforter teddies to the affected children as little encouragers.
Dr. Jürgen Vogt, Chairman of the Board and co-founder of the Frankfurt Foundation for Children with Cancer, said: “Since the foundation was established more than 25 years ago, we have been pursuing one goal: to continuously promote research in the field of childhood and adolescent cancer which has helped to reduce the mortality rate in childhood cancers. This would not have been possible without the generous support of companies like Mainova. Against this background, I am very pleased about the continuation of our trustful cooperation.”
In Germany, more than 2,000 children and young people are diagnosed with cancer every year. Fortunately, children’s cancer research has made considerable progress in recent years. Today, about 80 percent of young patients can be cured. But, at the same time, this means that every fifth child still does not survive. “This is why our vision remains: all children suffering from cancer should have a chance for a cure – and a chance for a future without long-term consequences,” added Dr Vogt.
Since 2014, the Arnold GmbH company has been supporting the important research work of the Frankfurt Foundation for Children with Cancer. In previous years, we received a donation amount corresponding to the year in each case. This is not possible this year due to the current situation. However, from the point of view of Managing Director Markus Bernsteiner, a donation still had to be made. And so we were able to receive a magnificent 1,111 euros on 16.12.2020.
A heartfelt THANK YOU for this wonderful gesture and for many years of loyalty.
As a doctor and scientist, Prof. Zeuzem stands for the close integration of medical research, academic teaching and patient care.
It is a great pleasure for us to be able to continue and expand the successful cooperation between the University of Frankfurt and our Foundation with him as a link.
You can read more details about his appointment as dean and his vita here.
At this point we would like to take the opportunity to express our sincere thanks to Prof. Dr. Josef Pfeilschifter, who, as a member of the Board of Directors accompanied the important work of the Frankfurt Foundation for Children with Cancer with great commitment for 16 years.
His membership was linked to his position as Dean of the Faculty of Medicine at Goethe University Frankfurt. We wish Prof. Pfeilschifter all the best for the future.
This year, the company SINTRONICS GmbH from Schöneck has once again made a great donation to us. With 3,000 Euros they support the important research work in the field of cancer in children and adolescents.
A big thank you for this great commitment.
Dr. Constanze Schneider received the award for her scientific work on “SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia”, which was published in the journal “Nature Medicine”.
Until now, in acute myeloid leukaemia (AML) it was not possible to predict which patients would respond to standard chemotherapy with cytarabine. With SAMHD1, a new biomarker was discovered that can be used to identify patients who respond to chemotherapy with a high degree of accuracy.
Contact
Frankfurt Foundation for children with cancer Komturstraße 3a 60528 Frankfurt
Click on the graphic below. You will be redirected to the Gooding site where you can shop in one of the more than 1,800 affiliated online shops. The participating shops support charitable organisations with a bonus of 5% of the purchase value on average. By logging in via the graphic, the Frankfurt Foundation for Children with Cancer is preselected as a premium recipient.
